Teladoc Health, Inc. (TDOC) Financial Statements (2023 and earlier)

Company Profile

Business Address 2 MANHATTANVILLE ROAD
PURCHASE, NY 10577
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8011 - Offices and Clinics of Doctors of Medicine (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments89678751742412266137
Cash and cash equivalents893733514424435055
Short-term investments3533 791682
Receivables1691695744271412
Inventory, net of allowances, customer advances and progress billings7356     
Inventory7356     
Other undisclosed current assets87471465732
Total current assets:1,2251,06058853315683152
Noncurrent Assets
Operating lease, right-of-use asset474726
Property, plant and equipment27291010976
Intangible assets, net (including goodwill)16,41416,60297298565821372
Goodwill14,50414,58174673749918856
Intangible assets, net (excluding goodwill)1,9102,0212252471602515
Other noncurrent assets211871100
Total noncurrent assets:16,50916,6961,01599666822178
TOTAL ASSETS:17,73517,7551,6031,529824304230
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities166155504123129
Accounts payable474698422
Accrued liabilities131162200
Employee-related liabilities929531281796
Taxes payable13233   
Interest and dividends payable1211000
Deferred revenue765212
Debt 435  21
Restructuring reserve   0 00
Estimated litigation liability 211111
Deferred revenue and credits411
Contract with customer, liability8
Other liabilities302183522
Other undisclosed current liabilities5960149833
Total current liabilities:3313339062402118
Noncurrent Liabilities
Long-term debt and lease obligation1,2671,4234654152074225
Long-term debt, excluding current maturities1,2261,3804404152074225
Operating lease, liability424325
Liabilities, other than long-term debt81106336588
Deferred revenue42 
Deferred tax liabilities, net   1
Deferred income tax liabilities7610222
Other liabilities12126587
Total noncurrent liabilities:1,3491,5294994212125033
Total liabilities:1,6801,8625894832537151
Stockholders' equity
Stockholders' equity attributable to parent16,04615,8841,0141,013559231179
Common stock0000000
Additional paid in capital17,47316,8581,5391,435866436309
Accumulated other comprehensive income (loss)(6)19(17)(13)4(0)(0)
Accumulated deficit(1,421)(993)(508)(409)(312)(205)(131)
Total stockholders' equity:16,04615,8841,0141,013559231179
Other undisclosed liabilities and equity910 32132 
TOTAL LIABILITIES AND EQUITY:17,73517,7551,6031,529824304230

Income Statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2,0331,09455341823312377
Cost of revenue(650)(394)(189)(129)(62)(32)(21)
Cost of goods and services sold(650)(391)(184)    
Gross profit:1,3827003652891729156
Operating expenses(1,648)(1,206)(445)(322)(225)(142)(107)
Other undisclosed operating loss   (38)(22)(11)(5)
Operating loss:(266)(506)(80)(71)(75)(63)(56)
Nonoperating income
(Other Nonoperating income)
5      
Interest and debt expense(44)(9)     
Loss from continuing operations before equity method investments, income taxes:(304)(515)(80)(71)(75)(63)(56)
Other undisclosed loss from continuing operations before income taxes(80)(60)(29)(26)(32)(11)(2)
Loss from continuing operations before income taxes:(385)(576)(109)(97)(107)(74)(58)
Income tax expense (benefit)(44)9111(0)0(1)(0)
Net loss available to common stockholders, diluted:(429)(485)(99)(97)(107)(74)(58)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(429)(485)(99)(97)(107)(74)(58)
Other comprehensive income (loss)(25)36(4)  0(0)
Comprehensive loss:(454)(449)(103)(97)(107)(74)(58)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (17)4  
Comprehensive loss, net of tax, attributable to parent:(454)(449)(103)(114)(103)(74)(58)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: